Articles

A retrospective analysis of data from the CELESTIAL trial has demonstrated the potential role for cabozantinib in patients with advanced hepatocellular carcinoma and Child-Pugh B liver cirrhosis.

Cabozantinib Showcases Efficacy in Patients with HCC and Child-Pugh B

Videos

Heinz-Josef Lenz, MD, FACP, discusses optimal sequencing strategies for the treatment of patients with colorectal cancer. 

Dr. Lenz on Optimal Sequencing Strategies in CRC

Anthony B. El-Khoueiry, MD, discusses the frontline treatment landscape of hepatocellular carcinoma.  



Dr. El-Khoueiry on the Frontline Treatment Landscape in HCC 

Renowned oncologist and cancer researcher will begin inaugural position in September.

Steven Grossman, MD, PhD, Named Cancer Physician in Chief of USC Norris Comprehensive Cancer Center


Heinz-Josef Lenz, MD, FACP, discusses updated results from the phase II CheckMate-142 trial in metastatic colorectal cancer.
 

Dr. Lenz on Updated Results of the CheckMate-142 Trial in mCRC

Anthony B. El-Khoueiry, MD, associate professor of clinical medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, discusses research on biomarkers in hepatocellular carcinoma (HCC).

USC Norris

Latest from USC Norris

New content coming soon, please check back later.